Research Analysts Set Expectations for Palomar Q3 Earnings

Palomar Holdings, Inc. (NASDAQ:PLMR) – Investment analysts at Zacks Research decreased their Q3 2027 earnings per share (EPS) estimates for Palomar in a research report issued on Monday, June 29th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $2.79 for the quarter, down from their prior forecast of $2.91. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Palomar’s current full-year earnings is $8.93 per share. Zacks Research also issued estimates for Palomar’s FY2027 earnings at $9.72 EPS.

Other equities analysts have also issued research reports about the stock. Weiss Ratings raised shares of Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, June 18th. JPMorgan Chase & Co. decreased their target price on shares of Palomar from $160.00 to $150.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 26th. Keefe, Bruyette & Woods lowered their target price on shares of Palomar from $186.00 to $159.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Finally, Piper Sandler lowered their target price on shares of Palomar from $151.00 to $132.00 and set an “overweight” rating for the company in a research note on Monday, May 11th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $147.75.

Palomar Price Performance

NASDAQ:PLMR opened at $126.39 on Wednesday. Palomar has a 12-month low of $100.81 and a 12-month high of $156.55. The firm has a market cap of $3.35 billion, a price-to-earnings ratio of 17.60 and a beta of 0.44. The company’s 50-day moving average is $115.23 and its two-hundred day moving average is $122.56. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31.

Palomar (NASDAQ:PLMR) last announced its earnings results on Wednesday, May 6th. The company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.17 by $0.14. Palomar had a net margin of 20.11% and a return on equity of 22.62%. The firm had revenue of $278.94 million during the quarter, compared to the consensus estimate of $557.79 million. During the same quarter in the previous year, the company posted $1.87 EPS. The firm’s revenue for the quarter was up 59.7% on a year-over-year basis.

Insider Buying and Selling at Palomar

In other news, CEO Mac Armstrong sold 3,500 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $112.96, for a total transaction of $395,360.00. Following the completion of the transaction, the chief executive officer owned 329,388 shares of the company’s stock, valued at $37,207,668.48. This represents a 1.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Jon Christianson sold 1,937 shares of the company’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $128.62, for a total transaction of $249,136.94. Following the transaction, the president directly owned 65,919 shares of the company’s stock, valued at approximately $8,478,501.78. This represents a 2.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 19,114 shares of company stock worth $2,351,100 in the last 90 days. 3.70% of the stock is owned by company insiders.

Hedge Funds Weigh In On Palomar

A number of large investors have recently bought and sold shares of the stock. Geneos Wealth Management Inc. acquired a new position in shares of Palomar in the 4th quarter valued at $32,000. Kestra Advisory Services LLC acquired a new stake in shares of Palomar during the 4th quarter worth $33,000. Rockefeller Capital Management L.P. increased its holdings in shares of Palomar by 81.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after buying an additional 132 shares during the last quarter. Clearstead Advisors LLC raised its position in shares of Palomar by 31.0% in the 3rd quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock worth $46,000 after buying an additional 94 shares during the period. Finally, Frazier Financial Advisors LLC purchased a new position in shares of Palomar in the 4th quarter worth $54,000. Hedge funds and other institutional investors own 90.25% of the company’s stock.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.